Improvement in rheumatoid sarcopenia with biological therapy; muscle ultrasound study by Zehra Özsoy, Merve Hafızoğlu, Zeynep Öztürk, Zeynep Şahiner, Didem Karaduman, Güllü Sandal Uzun, Erdinç Ünaldı, Yağmur Tahıllıoğlu, Meltem Gülhan Halil

Subjects: Get full text

Tuberculosis infection in patients with rheumatic diseases under different treatments by Tianhui Liu, Hongxuan Yan, Mengqiu Gao

Subjects: “…bDMARDs…”
Get full text

Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by Yasemin Tombak, Ajda Bal, Emel Eksioglu, Nihan Abidin, Ozgur Zeliha Karaahmet, Deniz Dulgeroglu

Subjects: “…bDMARDs…”
Get full text

Risk of serious bacterial infections in inflammatory rheumatic or bowel disease patients during biological therapies: nationwide Danish cohort study by Emma Cathrine Højberg Platz, Gustav Emil Laugesen, Anne Ahrens Østergaard, Keld-Erik Byg, Inge Petersen, Isik Somuncu Johansen

Subjects: “…bDMARDs…”
Get full text

Outcomes of children with juvenile idiopathic arthritis receiving biological disease-modifying anti-rheumatic drugs: a retrospective single-centre experience from IndiaResearch in... by Pavneet Kaur, Farheen Kizhakkeveettil Saheer, Bala Siva Rama Krishna J, Banoth Sreeshanth, Ayisha Kavil Peedika, Bareddy Sai Thrisha Reddy, Ashish Datt Upadhyay, Rakesh Lodha, Sushil Kumar Kabra, Narendra Bagri

Subjects: Get full text

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region by Zoltán Kaló, Zoltán Vokó, Andrew Östör, Emma Clifton-Brown, Radu Vasilescu, Alysia Battersby, Edward Gibson

Subjects: “…Biological disease-modifying antirheumatic drugs (bDMARDs)…”
Get full text

Comparison of seropositive and seronegative rheumatoid arthritis patients using or about to be initiated with biological DMARDS by Zehra Özsoy, Şerife Asya Germe, Gizem Ayan, Güllü Sandal Uzun, Mustafa Ekici, Erdinç Ünaldı, Levent Kılıç, Ali Akdoğan, Şule Apras Bilgen, Sedat Kiraz, Ali İhsan Ertenli

Subjects: Get full text

Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY) by Hideto Kameda, Kentaro Ishii, Junna Kiriyama, Toshiaki Mikami, Hideya Uratsuji, Akimichi Morita

Subjects: Get full text

Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world data by Delphine Bertrand, Elias De Meyst, Michaël Doumen, Diederik De Cock, Johan Joly, Barbara Neerinckx, Sofia Pazmino, Nele Pype, Tom Conings, René Westhovens, Patrick Verschueren

Subjects: Get full text

Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies by Philip J. Mease, Joseph F. Merola, Yoshiya Tanaka, Laure Gossec, Iain B. McInnes, Christopher T. Ritchlin, Robert B. M. Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates

Subjects: Get full text